Learn more

TELIGENE LTD

Overview
  • Total Patents
    34
  • GoodIP Patent Rank
    86,556
  • Filing trend
    ⇧ 300.0%
About

TELIGENE LTD has a total of 34 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are CYSTIC FIBROSIS FOUND THERAPEUTICS INC, MELINTA THERAPEUTICS INC and SILVERSTONE PHARMA.

Patent filings per year

Chart showing TELIGENE LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhang Dawei 34
#2 Xia Xiaoyang 13

Latest patents

Publication Filing date Title
WO2020228747A1 Substituted macrocycles useful as kinase inhibitors
US2020290968A1 Maleate salts of (e)-n-(3-cyano-7-ethoxy-4-((4-phenoxyphenyl)amino) quinolin-6-yl)-4-(dimethylamino)but-2-enamide and crystalline forms thereof
EP3661935A1 Substituted pyrazolopyrimidines useful as kinases inhibitors
WO2018137679A1 Process for the Preparation of (10R) -7- (2-aminoacetyl) amino-12-fluoro-2, 10, 16-trimethyl-15-oxo-10, 15, 16, 17-tetrahydro-2H-8, 4- (metheno) pyrazolo [4, 3-h] [2, 5, 11] -benzoxadiazacyclotetradecine-3-carbonitrile
CN109715142A 2-Propen-1-amine polymer with(chloromethyl)oxirane carbonate for tabletting
CN107922354A Heterocyclic compound as IDH2 inhibitor
EP3183256A1 Substituted macrocycles useful as kinases inhibitors and methods of use thereof
WO2016026423A1 Substituted macrocycles useful as kinases inhibitors and methods of use thereof
WO2014139391A1 Substituted pyridine compounds as kinases inhibitors
WO2013166952A1 Substituted aminoquinazolines useful as kinases inhibitors
KR20140093223A Quinazoline derivatives as kinases inhibitors and methods of use thereof
US2014350050A1 Pyridine compounds as inhibitors of kinase